As a component of the Society for Immunotherapy of Cancer's (SITC) regional, live Advances in Cancer Immunotherapy™ (ACI) programs, SITC is pleased to offer free online, introductory, CME-, CPE- and CNE-accredited programs via the society's online learning portal, SITC Cancer Immunotherapy connectED. These online activities provide an overview of basic immunology principles and the mechanisms and clinical applications of immunotherapy.
If you missed the opportunity to attend an Advances in Cancer Immunotherapy™ event, you can still obtain the education and CME, CPE and/or CNE credits through many of the online programs listed here.
Log in to the free ACI webinars to learn about new treatment approvals and emerging scientific data relating to clinical applications of cancer immunotherapy. Hosted by experts in the field, the webinars provide an opportunity to continue your learning from this ACI program and interact with faculty during a dedicated question-and-answer session.
Advances in Cancer ImmunotherapyTM Webinar Series - Updates from the FieldThursday, May 23, 2019; 3-4 p.m. CST
Advances in Cancer Immunotherapy™ On-Demand Webinar Recordings
Complete these free, interactive online courses to deepen your understanding of cancer immunotherapy and learn about the most recent FDA approvals and the latest guidelines on how to treat immune-related adverse events. Five courses each featuring different disease states and one course addresses how to overcome practical barriers to implementation, which are critical for helping your staff to help patients obtain reimbursement for immunotherapy. Each course will take approximately 45 minutes to complete and is eligible for CME, CNE or CPE credits.
In addition to a presentation (with audio), this online course includes links to the original trials, the latest FDA approvals, real-world case studies and questions to help deepen understanding and retention. There is also a printable chart outlining best practices for treating immune-related adverse effects and a link to the Cancer Immunotherapy Guidelines which can support decision-making.
Ask questions as leading experts discuss the most recent immunotherapy treatment standards for specific disease states – stemming from SITC’s Cancer Immunotherapy Guidelines.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org